Pass the Pre-Rolls, Please: Thanksgiving Holiday Cannabis Sales See Double-Digit Year-Over-Year Growth
29 Novembre 2022 - 2:03PM
Business intelligence from Akerna (Nasdaq: KERN), a leading
enterprise software company and the developer of the most
comprehensive technology infrastructure, ecosystem, and compliance
engine powering the global cannabis industry, delivered data
showing that Green Wednesday and Black Friday are on track yet
again to become the second- and third-highest grossing sale days
for regulated cannabis in the U.S. for 2022. These holiday sales
days are only trumped by the record-setting sales that took place
on 420, the day marking the societal celebration of cannabis. From
November 23 through November 26, the Thanksgiving holiday weekend
delivered over $289 million in sales, collectively up 12.7% year
over year.
The cannabis industry saw double-digit growth for two of the top
sales days year-to-date: Green Wednesday and Black Friday. Green
Wednesday, the day before Thanksgiving, was the most fruitful sales
day for cannabis, raking in over $116 million in sales, showing a
16% increase year-over-year. Naturally, as many retailers were
closed on Thanksgiving Day, Thursday’s sales were low, but picked
back up for Black Friday closing in on over $115 million in sales,
a 14% increase year-over-year.
“Cannabis has become an integral element of the Thanksgiving
holiday shopping tradition,” says Jessica Billingsley, Akerna CEO.
“Visibility and participation in the holiday shopping season is a
perfect opportunity for operators and brands looking to cement
their place in the hearts and minds of their customers. For
operators and brands to effectively participate and increase their
visibility, it is critical to focus on differentiation and
producing efficiently at scale.”
Additional sales data over the holiday weekend (November 23 –
November 26, 2022):
- Category sales
- Flower: 48.7%
- Cartridge/Pens: 32.3%
- Concentrates: 11.6%
- Infused Edibles: 5.8%
- Other: 1.6%
- Purchaser demographics - gender
- Purchaser demographics - age
- Under 30 years old: 26.6%
- 30-40 years old: 31%
- 40-50 years old: 21.3%
- 50-60 years old: 11.8%
- Over 60 years old: 9.3%
- Average order total (average dollar
spend per purchase)
- Medical: $111.77
- Recreational: $68.60
- Average basket size (average number
of items purchased per order)
- Medical: 3.55 items
- Recreational: 3.53 items
About AkernaAkerna (Nasdaq: KERN) is
an enterprise software company focused on compliantly serving the
cannabis, hemp, and CBD industry. First launched in
2010, Akerna has tracked more than $30 billion in
cannabis sales to date and is the first cannabis software company
listed on Nasdaq. Using connected data and information to
propel the cannabis industry forward, Akerna empowers
businesses, governments, patients, and consumers to make smart
decisions.
The Company's cornerstone technology, MJ Platform, the world's
leading infrastructure as a service platform, powers retailers,
manufacturers, brands, distributors, and
cultivators. Akerna also offers a complete suite of
professional consulting services and data analytics for businesses
as well as solo sciences, Leaf Data Systems, Trellis, Ample
Organics, Viridian Sciences and 365 Cannabis. For more
information, visit https://www.akerna.com/.
Forward-Looking StatementsCertain statements
made in this release and any accompanying statements by management
are "forward-looking statements" within the meaning of the "safe
harbor" provisions of the United States Private Securities
Litigation Reform Act of 1995. When used in this press release, the
words "estimates," "projected," "expects," "anticipates,"
"forecasts," "plans," "intends," "believes," "seeks," "may,"
"will," "should," "future," "propose" and variations of these words
or similar expressions (or the negative versions of such words or
expressions) are intended to identify forward-looking statements.
Such forward-looking statements include but participation in the
conference, Akerna's future business plans, Akerna's potential
business strengths in the market and any other statements
expressing the views of Akerna's management on future business
results or strategy. These forward-looking statements are not
guarantees of future performance, conditions or results, and
involve a number of significant known and unknown risks,
uncertainties, assumptions and other important factors, many of
which are outside Akerna's control, that could cause actual results
or outcomes (including, without limitation, the results of Akerna's
contracts, strategic initiatives, and business plans as described
herein) to differ materially from those discussed in the
forward-looking statements. Important factors, among others that
may affect actual results or outcomes, include (i) Akerna's ability
to recognize the anticipated benefits of being a public company,
(ii) competition, (iii) Akerna's ability to grow and manage growth
profitably, (iv) Akerna's ability to maintain relationships with
customers and suppliers and retain its management and key
employees, (v) costs related to being a public company, (vi)
changes in applicable laws or regulations, (vii) Akerna's ability
to identify, complete and integrate acquisitions, including
Viridian, and achieve expected synergies and operating efficiencies
in connection with acquired businesses, (viii) and other risks and
uncertainties disclosed from time to time in Akerna's filings with
the US Securities and Exchange Commission, including those under
"Risk Factors" therein. Actual results, performance, or
achievements may differ materially, and potentially adversely, from
any projections and forward-looking statements and the assumptions
on which those vary from forward-looking statements are based.
There can be no assurance that the data contained herein is
reflective of future performance to any degree. You are cautioned
not to place undue reliance on forward-looking statements as a
predictor of future performance as projected financial and other
information, are based on estimates and assumptions that are
inherently subject to various significant risks, uncertainties and
other factors, many of which are beyond Akerna's control. All
information herein speaks only as of the date hereof, in the case
of information about Akerna, or the date of such information, in
the case of information from persons other than Akerna. Akerna
undertakes no duty to update or revise the information contained
herein. Forecasts and estimates regarding Akerna's industry and end
markets are based on sources believed to be reliable; however,
there can be no assurance these forecasts and estimates will prove
accurate in whole or in part.
Media ContactMeghan Shinepr@akerna.com
Grafico Azioni Akerna (NASDAQ:KERN)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Akerna (NASDAQ:KERN)
Storico
Da Gen 2024 a Gen 2025